[特比萘芬诱发的亚急性皮肤型红斑狼疮。病例报告及文献复习]
[Terbinafine-induced subacute cutaneous lupus erythematosus. Case report and review of the literature].
作者信息
Matthes T, Hagedorn M
机构信息
Hautklinik des Klinikum Darmstadt, Darmstadt.
出版信息
Hautarzt. 2004 Jul;55(7):653-7. doi: 10.1007/s00105-004-0731-6.
PMID:15146276
Abstract
We report on a patient with terbinafine-induced SCLE covering clinical, histopathological and serological findings. Positive serological results included ANA, SS-A (Ro)-antibodies and anti-histone-antibodies with specificity for H1 and H3. The literature on terbinafine-induced SCLE is reviewed. We discuss H1- and H3-specific anti-histone antibodies as a possible diagnostic criterion of drug-induced SCLE.
摘要
我们报告了1例由特比萘芬引起的亚急性皮肤型红斑狼疮患者，涵盖了临床、组织病理学和血清学检查结果。血清学检查阳性结果包括抗核抗体、抗SS-A（Ro）抗体以及对H1和H3具有特异性的抗组蛋白抗体。本文回顾了关于特比萘芬引起亚急性皮肤型红斑狼疮的文献。我们讨论了H1和H3特异性抗组蛋白抗体作为药物性亚急性皮肤型红斑狼疮可能的诊断标准。
相似文献
1
[Terbinafine-induced subacute cutaneous lupus erythematosus. Case report and review of the literature].
Hautarzt. 2004 Jul;55(7):653-7. doi: 10.1007/s00105-004-0731-6.
2
Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature.
J Dtsch Dermatol Ges. 2008 Oct;6(10):823-7, 823-8. doi: 10.1111/j.1610-0387.2008.06806.x. Epub 2008 Jun 17.
3
Terbinafine-induced subacute cutaneous lupus erythematosus.
J Am Acad Dermatol. 2001 Jun;44(6):925-31. doi: 10.1067/mjd.2001.114565.
4
Terbinafine-induced subacute cutaneous lupus erythematosus.
Br J Dermatol. 1998 Dec;139(6):1132-3. doi: 10.1046/j.1365-2133.1998.2576q.x.
5
Terbinafine-induced subacute cutaneous lupus erythematosus.
Acta Derm Venereol. 2004;84(6):472-4. doi: 10.1080/00015550410018361.
6
[Subacute cutaneous lupus erythematosus induced by terbinafine].
Harefuah. 2006 Jul;145(7):480-2, 552.
7
Exacerbation of systemic lupus erythematosus induced by terbinafine.
Br J Dermatol. 1998 Dec;139(6):1133. doi: 10.1046/j.1365-2133.1998.2576r.x.
8
Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: a report of 5 cases.
Arch Dermatol. 2001 Sep;137(9):1196-8. doi: 10.1001/archderm.137.9.1196.
9
[Drug-induced subacute cutaneous lupus erythematosus: repeated occurrence following treatment with terbinafine].
Hautarzt. 2014 Jun;65(6):548-52. doi: 10.1007/s00105-013-2747-2.
10
Terbinafine-induced subacute cutaneous lupus erythematosus.
Dermatology. 2006;212(1):59-65. doi: 10.1159/000089024.
引用本文的文献
1
[Terbinafine : Drug-induced lupus erythematodes and triggering of psoriatic skin lesions].
Hautarzt. 2016 Sep;67(9):724-31. doi: 10.1007/s00105-016-3844-9.
2
[Drug-induced subacute cutaneous lupus erythematosus: repeated occurrence following treatment with terbinafine].
Hautarzt. 2014 Jun;65(6):548-52. doi: 10.1007/s00105-013-2747-2.
本文引用的文献
1
Hair loss after terbinafine treatment.
Br J Dermatol. 2001 Nov;145(5):842. doi: 10.1046/j.1365-2133.2001.04423.x.
2
Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: a report of 5 cases.
Arch Dermatol. 2001 Sep;137(9):1196-8. doi: 10.1001/archderm.137.9.1196.
3
Terbinafine-induced subacute cutaneous lupus erythematosus.
J Am Acad Dermatol. 2001 Jun;44(6):925-31. doi: 10.1067/mjd.2001.114565.
4
Drug-induced lupus associated with COL-3: report of 3 cases.
Arch Dermatol. 2001 Apr;137(4):471-4.
5
[Oral terbinafine-induced plantar pustular psoriasis].
Ann Dermatol Venereol. 2000 Mar;127(3):279-81.
6
Terbinafine-induced neutropenia.
Br J Dermatol. 1999 Jun;140(6):1196-7.
7
Terbinafine-induced subacute cutaneous lupus erythematosus.
Br J Dermatol. 1998 Dec;139(6):1132-3. doi: 10.1046/j.1365-2133.1998.2576q.x.
8
Hypersensitivity syndrome reaction to oral terbinafine.
Australas J Dermatol. 1998 Aug;39(3):171-2. doi: 10.1111/j.1440-0960.1998.tb01275.x.
9
Terbinafine-induced acute generalized exanthematous pustulosis.
Br J Dermatol. 1998 Apr;138(4):709-10. doi: 10.1046/j.1365-2133.1998.02195.x.
10
Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature.
Br J Dermatol. 1998 Mar;138(3):529-32. doi: 10.1046/j.1365-2133.1998.02140.x.
Zotero 插件